Perez Foglierini Mathilde, MSc

Publications -> 20816

• AncesTree: An interactive immunoglobulin lineage tree visualizer
  Foglierini, M. Pappas, L. Lanzavecchia, A. Corti, D. Perez, L.
  in PLoS Comput Biol (2020) Vol.16 ppe1007731
  
• Deciphering and predicting CD4+ T cell immunodominance of influenza virus hemagglutinin
  Cassotta, A. Paparoditis, P. Geiger, R. Mettu, R. R. Landry, S. J. Donati, A. Benevento, M. Foglierini, M. Lewis, D. J. M. Lanzavecchia, A. Sallusto, F.
  in J Exp Med (2020) Vol.217 pp
  
• Virus-Like Particles and Nanoparticles for Vaccine Development against HCMV
  Perotti, M. Perez, L.
  in Viruses (2020) Vol.12 pppii: E35
  
• Protection against influenza infection requires early recognition by inflammatory dendritic cells through C-type lectin receptor SIGN-R1
  Palomino-Segura, M. Perez, L. Farsakoglu, Y. Latino, I. D'Antuono, R. Chatziandreou, N. Pizzagalli, D. U. Wang, G. Garcia-Sastre, A. Sallusto, F. Carroll, M. C. Neyrolles, O. Gonzalez, S. F.
  in Nat Microbiol (2019) Vol.4 pp1930-1940
  
• HCMV Envelope Glycoprotein Diversity Demystified
  Foglierini, M. Marcandalli, J. Perez, L.
  in Front Microbiol (2019) Vol.10 pp1005
  
• Induction of Potent Neutralizing Antibody Responses by a Designed Protein Nanoparticle Vaccine for Respiratory Syncytial Virus
  Marcandalli, J. Fiala, B. Ols, S. de van der Schueren, W. Snijder, J. Hodge, E. Benhaim, M. Ravichandran, R. Carter, L. Sheffler, W. Brunner, L. Lawrenz, M. Dubois, P. Lanzavecchia, A. Sallusto, F. Lee, K. K. Veesler, D. Correnti, C. E. Stewart, L. J. Baker, D. Lore, K. Perez, L. King, N. P.
  in Cell (2019) Vol.176 pp1420-1431 e17
  * J. Marcandalli and B. Fiala contributed equally to this work. L. Perez and N. P. King contributed equally to this work and are co-corresponding authors.
• An Unbiased Screen for Human Cytomegalovirus Identifies Neuropilin-2 as a Central Viral Receptor
  Martinez-Martin, N. Marcandalli, J. Huang, C. S. Perotti, M. Foglierini, M. Ho, H. Dosey, A. M. Shriver, S. Payandeh, J. Leitner, A. Lanzavecchia, A. Perez, L. Ciferri, C.
  in Cell (2018) Vol.174 pp1158-1171
  * L. Perez and C. Ciferri contributed equally; N M-M, LP and CC are co-corresponding authors
• Human cytomegalovirus (HCMV)-specific T-cell but not neutralizing or ELISA IgG antibody responses to glycoprotein complexes gB, gHgLgO, and pUL128L correlate with protection against high HCMV viral load reactivation in solid-organ transplant recipients
  Lilleri, D. Zelini, P. Fornara, C. Rampino, T. Perez, L. Gabanti, E. Gerna, G.
  in J Med Virol (2018) Vol.90 pp1620-1628
  
• False human cytomegalovirus IgG-positivity at prenatal screening
  Furione, M. Sarasini, A. Arossa, A. Lilleri, D. Perez, L. Parea, M. Zavattoni, M. Spinillo, A. Marone, P. Baldanti, F.
  in J Clin Virol (2018) Vol.104 pp34-38
  
• A public antibody lineage that potently inhibits malaria infection through dual binding to the circumsporozoite protein
  Tan, J. Sack, B. K. Oyen, D. Piccoli, L. Barbieri, S. Foglierini, M. Fregni, C. S. Marcandalli, J. Jongo, S. Abdulla, S. Perez, L. Corradin, G. Varani, L. Sallusto, F. Sim, B. K. L. Hoffman, S. L. Kappe, S. H. I. Daubenberger, C. Wilson, I. A. Lanzavecchia, A.
  in Nat Med (2018) Vol.24 pp401-407
  * Tan J., Sack B. K., Oyen D., Zenklusen I., Piccoli L. contributed equally to this work.
• Mitochondrial dysfunction induced by a SH2 domain-targeting STAT3 inhibitor leads to metabolic synthetic lethality in cancer cells
  Genini, D. Brambilla, L. Laurini, E. Civenni, G. Pandit, S. D'Antuono, R. Perez, L. Levy, D. E. Pricl, S. Carbone, G. M. Catapano, C. V.
  in Proc Natl Acad Sci U S A (2017) Vol.114 ppE4924-E4933
  
• The C-terminal domain of TPX2 is made of alpha-helical tandem repeats
  Sanchez-Pulido, L. Perez, L. Kuhn, S. Andrade-Navarro, M. A.
  in BMC Struct Biol (2016) Vol.16 pp17
  Perez L. and Sanchez-Pulido L. contributed equally to this work.
• Antibody-guided vaccine design: identification of protective epitopes
  Lanzavecchia, A. Fruhwirth, A. Perez, L.
  in Curr Opin Immunol (2016) Vol.41 pp62-67
  
• Platelet-derived growth factor-alpha receptor is the cellular receptor for human cytomegalovirus gHgLgO trimer
  Kabanova, A. Marcandalli, J. Zhou, T. Baxa, U. Tsybovsky, Y. Lilleri, D. Silacci-Fregni, C. Foglierini, M. Fernandez-Rodriguez, B. M. Druz, A. Zhang, B. Geiger, R. Pagani, M. Sallusto, F. Kwong, P. D. Corti, D. Lanzavecchia, A. Perez, L.
  in Nat Microbiol (2016) Vol.1 pp16082
  Anna Kabanova, Jessica Marcandalli, Tongqing Zhou equally contributed to this work; Antonio Lanzavecchia1and Laurent Perez jointly supervised this work.
• Monoclonal antibodies to different components of the human cytomegalovirus (HCMV) pentamer gH/gL/pUL128L and trimer gH/gL/gO as well as antibodies elicited during primary HCMV infection prevent epithelial cell syncytium formation
  Gerna, G. Percivalle, E. Perez, L. Lilleri, D.
  in J Virol (2016) Vol.90 pp6216-23
  
• Protective monotherapy against lethal Ebola virus infection by a potently neutralizing antibody
  Corti, D. Misasi, J. Mulangu, S. Kanekiyo, M. Wollen, S. Ploquin, A. Doria-Rose, N. A. Staupe, R. P. Bailey, M. Shi, W. Choe, M. Marcus, H. Thompson, E. A. Cagigi, A. Silacci, C. Fernandez-Rodriguez, B. Perez, L. Sallusto, F. Vanzetta, F. Agatic, G. Cameroni, E. Kisalu, N. Gordon, I. Ledgerwood, J. E. Mascola, J. R. Graham, B. S. Muyembe-Tamfun, J. J. Trefry, J. C. Lanzavecchia, A.
  in Science (2016) Vol.351 pp1339-42
  Davide Corti and John Misasi equally contributed to this work; John C. Trefry, Antonio Lanzavecchia, and Nancy J. Sullivan equally contributed to this work.
• Hitting the right spot: Mechanism of action of OPB-31121, a novel and potent inhibitor of the Signal Transducer and Activator of Transcription 3 (STAT3)
  Brambilla, L. Genini, D. Laurini, E. Perez, L. Fermeglia, M. Carbone, G. M. Pricl, S. Catapano, C. V.
  in Mol Oncol (2015) Vol.9 pp1194-206
  
• Antibody-driven design of a human cytomegalovirus gHgLpUL128L subunit vaccine that selectively elicits potent neutralizing antibodies
  Kabanova, A. Perez, L. Lilleri, D. Agatic, G. Becattini, S. Preite, S. Fuschillo, D. Percivalle, E. Sallusto, F. Gerna, G. Corti, D. Lanzavecchia, A.
  in Proc Natl Acad Sci U S A (2014) Vol.111 pp17965-70
  A.K. and L.P. contributed equally to this work.
• Cross-neutralization of four paramyxoviruses by a human monoclonal antibody
  Corti, D. Bianchi, S. Vanzetta, F. Perez, L. Agatic, G. Guarino, B. Silacci, C. Marcandalli, J. Marsland, B. J. Piralla, A. Percivalle, E. Sallusto, F. Baldanti, F. Lanzavecchia, A.
  in Nature (2013) Vol.501 pp439-43
  
• Direct bacterial killing in vitro by recombinant Nod2 is compromised by Crohn’s disease-associated mutations
  Perez, L. H. Butler, M. Creasey, T. Gounarides, J. Petit, S. Ropenga, A. Ryder, N. Smith, K. Smith, P. Parkinson, S. J.
  in PLoS One (2010) Vol.5 ppe10915
  
• The plant TPX2 protein regulates prospindle assembly before nuclear envelope breakdown
  Vos, J. W. Pieuchot, L. Evrard, J. L. Bergdoll, M. de Ronde, D. Perez, L. H. Sardon, T. Vernos, I. Schmit, A. C.
  in Plant Cell (2008) Vol.20 pp2783-97
  
• Negative regulation of cell-cycle progression by RINGO/Speedy E
  Dinarina, A. Ruiz, E. J. O'Loghlen, A. Perez, L. Nebreda, A. R.
  in Biochem J (2007) Vol.410 pp535-42
  
• Quantitative SUMO-1 modification of a vaccinia virus protein is required for its specific localization and prevents its self-association
  Palacios, S. Perez, L. H. Welsch, S. Chmielarska, K. Melchior, F. Locker, J. K.
  in Mol Biol Cell (2005) Vol.16 pp2822-35
  
• Characterization of a new family of cyclin-dependent kinase activators
  Dinarina, A. Perez, L. H. Davila, A. Hunt, T. Nebreda, A. R.
  in Biochem J (2004) Vol.386 pp349-55
  
• Xkid chromokinesin is required for the meiosis I to meiosis II transition in Xenopus laevis oocytes
  Perez, L. H. Antonio, C. Flament, S. Nebreda, A. R.
  in Nat Cell Biol (2002) Vol.4 pp737-42
  
• Differential regulation of Cdc2 and Cdk2 by RINGO and cyclins
  Karaiskou, A. Perez, L. H. Ferby, I. Jessus, C. Nebreda, A. R.
  in J Biol Chem (2001) Vol.276 pp36028-34